Dr. Janet Woodcock, director of the F.D.A.'s Center for Drug Evaluation and Research, said the agency had faced similar questions before.
OTC drugs also fall under the jurisdiction of the FDA's Center for Drug Evaluation and Research.
Cox directs the Office of Antimicrobial Products in the FDA's Center for Drug Evaluation and Research.
"This drug has so much baggage," Dr. Murray Lumpkin, deputy director of the agency's Center for Drug Evaluation and Research, said after the vote.
Throckmorton is the deputy director of the FDA's Center for Drug Evaluation and Research.
The issue was also discussed in April 2009 at the FDA's Center for Drug Evaluation and Research Drug Safety Oversight Board.
Dr. Robert DeLap of the Food and Drug Administration's Center for Drug Evaluation and Research, could not say when a decision on phenylpropanolamine would be made.
Benson is the deputy director of the Division of Reproductive and Urologic Products at the FDA's Center for Drug Evaluation and Research.
Now, both offices are under the purview of the F.D.A.'s Center for Drug Evaluation and Research.
"We are concerned that these companies are misleading consumers," says Janet Woodcock, M.D., director of FDA's Center for Drug Evaluation and Research.
Dr. Janet Woodcock, director of the F.D.A.'s Center for Drug Evaluation and Research, said the agency had faced similar questions before.
OTC drugs also fall under the jurisdiction of the FDA's Center for Drug Evaluation and Research.
Cox directs the Office of Antimicrobial Products in the FDA's Center for Drug Evaluation and Research.
"This drug has so much baggage," Dr. Murray Lumpkin, deputy director of the agency's Center for Drug Evaluation and Research, said after the vote.
Throckmorton is the deputy director of the FDA's Center for Drug Evaluation and Research.
The issue was also discussed in April 2009 at the FDA's Center for Drug Evaluation and Research Drug Safety Oversight Board.
Dr. Robert DeLap of the Food and Drug Administration's Center for Drug Evaluation and Research, could not say when a decision on phenylpropanolamine would be made.
Benson is the deputy director of the Division of Reproductive and Urologic Products at the FDA's Center for Drug Evaluation and Research.
Now, both offices are under the purview of the F.D.A.'s Center for Drug Evaluation and Research.
"We are concerned that these companies are misleading consumers," says Janet Woodcock, M.D., director of FDA's Center for Drug Evaluation and Research.
